Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. [electronic resource] by
- Butler, Lisa M
- Liapis, Vasilios
- Bouralexis, Stelios
- Welldon, Katie
- Hay, Shelley
- Thai, Le M
- Labrinidis, Agatha
- Tilley, Wayne D
- Findlay, David M
- Evdokiou, Andreas
Producer: 20060809
In:
International journal of cancer vol. 119
Availability: No items available.
|
|
|
6.
|
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer. [electronic resource] by
- Zinonos, Irene
- Labrinidis, Agatha
- Lee, Michelle
- Liapis, Vasilios
- Hay, Shelley
- Ponomarev, Vladimir
- Diamond, Peter
- Zannettino, Andrew C W
- Findlay, David M
- Evdokiou, Andreas
Producer: 20100112
In:
Molecular cancer therapeutics vol. 8
Availability: No items available.
|
|
|
7.
|
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. [electronic resource] by
- Zinonos, Irene
- Labrinidis, Agatha
- Lee, Michelle
- Liapis, Vasilios
- Hay, Shelley
- Ponomarev, Vladimir
- Diamond, Peter
- Findlay, David M
- Zannettino, Andrew C W
- Evdokiou, Andreas
Producer: 20110525
In:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol. 26
Availability: No items available.
|
|
|
8.
|
Bone marrow lesions detected by specific combination of MRI sequences are associated with severity of osteochondral degeneration. [electronic resource] by
- Muratovic, Dzenita
- Cicuttini, Flavia
- Wluka, Anita
- Findlay, David
- Wang, Yuanyuan
- Otto, Sophia
- Taylor, David
- Humphries, Julia
- Lee, Yearin
- Labrinidis, Agatha
- Williams, Ruth
- Kuliwaba, Julia
Producer: 20161213
In:
Arthritis research & therapy vol. 18
Availability: No items available.
|
|
|
9.
|
Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis? [electronic resource] by
- Labrinidis, Agatha
- Liapis, Vasilios
- Thai, Le M
- Atkins, Gerald J
- Vincent, Cristina
- Hay, Shelley
- Sims, Natalie A
- Zannettino, Andrew C W
- Findlay, David M
- Evdokiou, Andreas
Producer: 20080701
In:
Blood vol. 111
Availability: No items available.
|
|
|
10.
|
Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. [electronic resource] by
- Diamond, Peter
- Labrinidis, Agatha
- Martin, Sally K
- Farrugia, Amanda N
- Gronthos, Stan
- To, L Bik
- Fujii, Nobutaka
- O'Loughlin, Peter D
- Evdokiou, Andreas
- Zannettino, Andrew C W
Producer: 20090929
In:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol. 24
Availability: No items available.
|
|
|
11.
|
|
|
|
12.
|
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs). [electronic resource] by
- Zinonos, Irene
- Labrinidis, Agatha
- Liapis, Vasilios
- Hay, Shelley
- Panagopoulos, Vasilios
- Denichilo, Mark
- Ponomarev, Vladimir
- Ingman, Wendy
- Atkins, Gerald J
- Findlay, David M
- Zannettino, Andrew C W
- Evdokiou, Andreas
Producer: 20150324
In:
Anticancer research vol. 34
Availability: No items available.
|
|
|
13.
|
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. [electronic resource] by
- Liapis, Vasilios
- Labrinidis, Agatha
- Zinonos, Irene
- Hay, Shelley
- Ponomarev, Vladimir
- Panagopoulos, Vasilios
- DeNichilo, Mark
- Ingman, Wendy
- Atkins, Gerald J
- Findlay, David M
- Zannettino, Andrew C W
- Evdokiou, Andreas
Producer: 20150421
In:
Cancer letters vol. 357
Availability: No items available.
|
|
|
14.
|
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. [electronic resource] by
- Liapis, Vasilios
- Zinonos, Irene
- Labrinidis, Agatha
- Hay, Shelley
- Ponomarev, Vladimir
- Panagopoulos, Vasilios
- Zysk, Aneta
- DeNichilo, Mark
- Ingman, Wendy
- Atkins, Gerald J
- Findlay, David M
- Zannettino, Andrew C W
- Evdokiou, Andreas
Producer: 20161213
In:
Cancer medicine vol. 5
Availability: No items available.
|
|
|
15.
|
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. [electronic resource] by
- Labrinidis, Agatha
- Diamond, Peter
- Martin, Sally
- Hay, Shelley
- Liapis, Vasilios
- Zinonos, Irene
- Sims, Natalie A
- Atkins, Gerald J
- Vincent, Cristina
- Ponomarev, Vladimir
- Findlay, David M
- Zannettino, Andrew C W
- Evdokiou, Andreas
Producer: 20090416
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15
Availability: No items available.
|
|
|
16.
|
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. [electronic resource] by
- Zinonos, Irene
- Luo, Ke-Wang
- Labrinidis, Agatha
- Liapis, Vasilios
- Hay, Shelley
- Panagopoulos, Vasilios
- Denichilo, Mark
- Ko, Chun-Hay
- Yue, Grace Gar-Lee
- Lau, Clara Bik-San
- Ingman, Wendy
- Ponomarev, Vladimir
- Atkins, Gerald J
- Findlay, David M
- Zannettino, Andrew C W
- Evdokiou, Andreas
Producer: 20150126
In:
International journal of oncology vol. 45
Availability: No items available.
|